Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
about
Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genesEGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatmentNon-canonical signaling mode of the epidermal growth factor receptor familyNuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.Nuclear localization of orphan receptor protein kinase (Ror1) is mediated through the juxtamembrane domain.The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus.Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3.Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locationsNuclear localization of epidermal growth factor receptor (EGFR) in ameloblastomas.The nuclear epidermal growth factor receptor signaling network and its role in cancer.Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2.Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor.Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.On mammary gland growth factors: roles in normal development and in cancerNuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor familyPML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776.The status of epidermal growth factor receptor in borderline ovarian tumours.Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Pathological Characteristics.CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification.EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer.Subcellular localization of EGFR in esophageal carcinoma cell lines.DNA Aptamers for the Characterization of Histological Structure of Lung Adenocarcinoma.CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response.Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration.EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact.Patterns of skin and soft tissue metastases from breast cancer according to subtypes: relationship between EGFR overexpression and skin manifestations.Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma.Emerging Roles of Fibroblast Growth Factor 10 in Cancer
P2860
Q24301779-C0C69CB3-4994-4B7D-B1A9-A064E1534918Q24338426-2CD2BEA8-BFE7-422B-96EA-FA2DF01F2E3CQ26773754-C8497556-ABE5-43E5-909A-F0C8648161D6Q33578803-9376F125-63B1-401A-819A-816AD5CCE51AQ33619947-B7E1C1A8-E056-4982-8F5E-985873551306Q34352437-D20473DA-FBA6-45EE-A472-24B9CD76DBC7Q34949789-C1083911-9F2F-4F31-AD34-CC267E665BAEQ35794308-7CCCC11F-B0BB-4252-888E-D17311B10F1CQ35831012-A9B30E85-118A-4ADF-8C56-7BD5A1399CF6Q35833106-0FD185F3-FD2D-4C36-8136-B57454D5F5F4Q35834849-FB438342-451E-4BDB-A94A-B02E07FE931AQ35956440-33C4DF61-468C-4A25-9A01-5E9E853915CEQ36054625-A60F7F4F-A558-4589-9900-FC25ABE4D398Q36113481-CE034A99-8430-4F41-A27E-5837ECA481E4Q36119485-3C378AB4-0BBD-4E1F-B343-27981EA17300Q36162605-B2B6BBBC-D27B-4E9A-82D8-5A18D5AC7CDDQ36187706-4E6D18DF-1F31-4DAA-B639-56D36CEB02B5Q36225686-E7801E10-A232-4B2F-8591-0903ECF06386Q36963030-3DAA86B3-081A-4279-8AE4-1793F470E148Q37017051-6BE5027A-3D36-4622-89D2-49EFA0D5FEC3Q37154185-71F723AD-FBC1-4DDF-975C-25922005429CQ37722121-46F8F507-76B8-445D-BE19-2A9E8D34CA08Q38407300-B1CD3087-1A63-48F9-9763-40A4EE4C188DQ38552978-28767BBC-7E89-4D16-8345-FFBCD2170BC6Q39028181-AF3E65ED-1D5E-4795-8F9D-011ED509C356Q40784649-FE22F786-7232-4700-B8B3-05EFF97B02F5Q41898283-E9BBB700-85BA-448D-AC36-85BF9E9B355BQ47932543-46A38D90-9420-475F-A999-C5EF7DE0F61AQ49787431-29378C56-47D8-4802-BB8A-A42F74E42E13Q53284577-0188D5A8-0DD8-4CE0-ACCA-36A8E29EB876Q53405626-43ED3857-F09B-43F4-A777-6900F9138928Q55460041-E6959383-A28D-4743-937E-61E7B2398E1AQ58566489-DD89B080-2E97-4BD6-B878-9121B168579D
P2860
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
@en
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
@nl
type
label
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
@en
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
@nl
prefLabel
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
@en
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
@nl
P2860
P50
P1433
P1476
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis
@en
P2093
Marija Petković
P2860
P2888
P304
P356
10.1038/MODPATHOL.2009.166
P577
2010-01-08T00:00:00Z